Unipharm was founded in 1975. We offer product portfolio consisting of a broad range of high quality generics for all major therapeutic areas. It is part of our long-term strategy to expand the product portfolio of off-patent blockbusters while at the same time offering a broader range of niche products within more narrow disease areas.

Unipharm’s products are developed in the CTD dossier format and produced in a manufacturing facility certified in compliance with Good Manufacturing Practices (GMP), which is recognized by the European Union (EU).